The King Hussein Cancer Award is officially inviting applications for its prestigious Lifetime Achievement Award, a distinction aimed at honoring Arab researchers who have dedicated their lives to the global fight against cancer.
This high-profile initiative seeks to celebrate the “pillars and pioneers” of oncology whose work has significantly advanced the understanding and treatment of the disease both within the Arab region and internationally.
The award highlights individuals who have made meaningful contributions through innovative research, the development of new drug protocols, or the acquisition of impactful patents.
Beyond scientific excellence, the selection committee is looking for nominees who have demonstrated a clear commitment to the Arab world through mentorship, leadership, and long-term collaborative efforts.
Funding and benefits
Winners of this prestigious honor will receive a $30,000 prize in recognition of their lifelong contributions to the field [4]. Each year, the award is granted to two outstanding applicants: one researcher based regionally within the Arab world and one based internationally.
In addition to the monetary prize, laureates will be formally recognized during the King Hussein Award Ceremony held in Amman, Jordan.
This event serves as a premier platform for winners to showcase their dedication to improving cancer prevention, diagnosis, and treatment on a global stage.
Application requirements and eligibility
To be eligible for nomination, candidates must hold an MD, PhD, or equivalent degree and maintain an affiliation with a reputable institution involved in cancer research.
Preference is given to scientists who have dedicated at least 50% of their career work specifically to cancer research and who have not previously received this award.
Candidates must also provide evidence of meaningful existing collaborations with researchers or institutions in the Arab world.
Eligibility extends to retired professionals, provided they have a proven track record of leadership and a continued commitment to supporting regional institutions through future collaborations.
The submission process is conducted in two phases, beginning with either a self-nomination or a nomination by an eligible colleague.
To qualify as a sponsor, nominators must hold a PhD or MD with at least 15 years of active research experience and a strong publication history.
Deadline
Prospective applicants and nominators are encouraged to create an account on the official King Hussein Cancer Award portal to initiate the two-phase submission process.
While the award is presented on an annual basis, interested parties should visit the official website to complete their applications and review the specific requirements for the current cycle.
To apply, visit The King Hussein Cancer Award call page. Visit our global opportunity page for more.
Summary not available at this time.
